Abstract
Prostate cancer is the most common solid tumor in adult men, with an estimated 230,000 new cases diagnosed in the USA in 2006. There is a greater concern for quality of life after prostate cancer treatment due to the younger age of diagnosis and increased survival rate. One goal of radical prostatectomy surgery is to limit any further impairment of erectile function. We examine the current understanding of the pathophysiology of ED following radical prostatectomy.
During erection, parasympathetic tone dominates and a number of molecular pathways mediate a decrease in intracellular Ca, corporal smooth muscle relaxation, increased penile arterial inflow, and tumescence. Nitric oxide (NO) is generally agreed upon as the principle neurotransmitter involved in initiating and maintaining penile smooth muscle relaxation, and thus erection. It is clear that the extent to which the cavernous nerves are salvaged or damaged during radical prostatectomy is directly proportional to a patient’s degree of postoperative ED. An emerging concept in the field of erectile dysfunction is penile homeostasis. In order for an erection to occur, the complex and unique sinusoidal morphology of the corpora cavernosa must be maintained. New light has been shed on this process with the identification and investigation of the morphogenic protein Sonic hedgehog (SHH), along with its downstream targets Patched 1 (PTCH1), Hox, bone morphogenetic proteins (BMPs), vascular endothelial growth factor (VEGF), and NOS.
It is believed that chronic hypoxia and denervation of erectile tissue following radical prostatectomy result in permanent ED via apoptosis of smooth muscle cells, deposition of collagen (scar), and penile fibrosis. Hypoxia also causes an increase in release of potent vasoconstrictor molecules such as endothelin-1, a pro-fibrotic peptide, with synthesis.
Active investigation continues in the fields of penile homeostasis, the pathophysiology of ED, control of inflammation and fibrosis, prevention or limitation of smooth muscle apoptosis, and neural regenerative strategies influenced by TGF-B1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jemal, A., et al. (2006) Cancer statistics 2006. CA Cancer J. Clin. 56(2), 106–130.
Vale, J. (2000) Erectile dysfunction following radical therapy for prostate cancer. Radiother. Oncol. 57(3), 301–305.
Kendirci, M., and Hellstrom, W.J. (2004) Current concepts in the management of erectile dysfunction in men with prostate cancer. Clin. Prostate Cancer 3(2), 87–92.
Katz, A. (2005) What happened? Sexual consequences of prostate cancer and its treatment. Can. Fam. Physician 51, 977–982.
Alivizatos, G., and Skolarikos, A. (2005) Incontinence and erectile dysfunction following radical prostatectomy: a review. Sci. World J. 5, 747–758.
Penson, D.F., et al. (2005) 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J. Urol. 173(5), 1701–1705.
Miyao, N., et al. (2001) Recovery of sexual function after nerve-sparing radical prostatectomy or cystectomy. Int. J. Urol. 8(4), 158–164.
Crawford, E.D., et al. (1997) Comparison of perspectives on prostate cancer: analyses of survey data. Urology 50(3), 366–372.
Litwin, M.S., et al. (1999) Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 54(3), 503–508.
Shindel, A., et al. (2005) Sexual dysfunction in female partners of men who have undergone radical prostatectomy correlates with sexual dysfunction of the male partner. J. Sex. Med. 2(6), 833–841; discussion 841.
Rabbani, F., et al. (2000) Factors predicting recovery of erections after radical prostatectomy. J. Urol. 164(6), 1929–1934.
Johannes, C.B., et al. (2000) Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J. Urol. 163(2), 460–463.
Leeson, T.S., and Leeson, C.R. (1965) The fine structure of cavernous tissue in the adult rat penis. Invest. Urol. 3(2), 144–154.
Goldstein, A.M.B., Meehan, J.P., and Zakhary, R. (1982) New observations on microarchitecture of corpora cavernosa in man and possible relationship to mechanism of erection. Urology 20, 259.
Breza, J., et al. (1989) Detailed anatomy of penile neurovascular structures: surgical significance. J. Urol. 141(2), 437–443.
Kim, E.D., Blackburn, D., and McVary, K.T. (1994) Post-radical prostatectomy penile blood flow: assessment with color flow Doppler ultrasound. J. Urol. 152(6 Pt 2), 2276–2279.
Mulhall, J.P., et al. (2002) Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J. Urol. 167(3), 1371–1375.
Rogers, C.G., Trock, B.P., and Walsh, P.C. (2004) Preservation of accessory pudendal arteries during radical retropubic prostatectomy: surgical technique and results. Urology 64(1), 148–151.
Aboseif, S.R., et al. (1989) Penile venous drainage in erectile dysfunction. Anatomical, radiological and functional considerations. Br. J. Urol. 64(2), 183–190.
Andersson, K.E., and Wagner, G. (1995) Physiology of penile erection. Physiol. Rev. 75(1), 191–236.
Walsh, P.C., and Donker, P.J. (1982) Impotence following radical prostatectomy: insight into etiology and prevention. J. Urol. 128(3), 492–497.
Ignarro, L.J., et al. (1990) Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem. Biophys. Res. Commun. 170(2), 843–850.
Holmquist, F., et al. (1991) Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit. Acta Physiol. Scand. 143(3), 299–304.
Kim, N., et al. (1991) A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J. Clin. Invest. 88(1), 112–118.
Pickard, R.S., Powell, P.H., and Zar, M.A. (1991) The effect of inhibitors of nitric oxide biosynthesis and cyclic GMP formation on nerve-evoked relaxation of human cavernosal smooth muscle. Br. J. Pharmacol. 104(3), 755–759.
Burnett, A.L., et al. (1992) Nitric oxide: a physiologic mediator of penile erection. Science 257(5068), 401–403.
Rajfer, J., et al. (1992) Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N. Engl. J. Med. 326(2), 90–94.
Trigo-Rocha, F., et al. (1993) The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic, noncholinergic neurotransmission in canine penile erection. J. Urol. 149(4), 872–877.
Burnett, A.L., and Musicki, B. (2005) The nitric oxide signaling pathway in the penis. Curr. Pharm. Des. 11(31), 3987–3994.
Rajasekaran, M., et al. (1998) Ex vivo expression of nitric oxide synthase isoforms (eNOS/iNOS) and calmodulin in human penile cavernosal cells. J. Urol. 160(6 Pt 1), 2210–2215.
Ehren, I., Adolfsson, J., and Wiklund, N.P. (1994) Nitric oxide synthase activity in the human urogenital tract. Urol. Res. 22(5), 287–290.
Magee, T.R., et al. (2003) Protein inhibitor of nitric oxide synthase (NOS) and the N-methyl-D-aspartate receptor are expressed in the rat and mouse penile nerves and colocalize with penile neuronal NOS. Biol. Reprod. 68(2), 478–488.
Gonzalez-Cadavid, N.F., and Rajfer, J. (2000) Therapeutic stimulation of penile nitric oxide synthase (NOS) and related pathways. Drugs Today (Barc) 36(2–3), 163–174.
Podlasek, C.A., et al. (2001) Analysis of NOS isoform changes in a post radical prostatectomy model of erectile dysfunction. Int. J. Impot. Res. 13(Suppl 5), S1–15.
Hurt, K.J., et al. (2002) Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc. Natl. Acad. Sci. USA 99(6), 4061–4066.
Burnett, A.L. (2004) Novel nitric oxide signaling mechanisms regulate the erectile response. Int. J. Impot. Res. 16(Suppl 1), S15–S19.
Podlasek, C.A., et al. (2001) Characterization and localization of nitric oxide synthase isoforms in the BB/WOR diabetic rat. J. Urol. 166(2), 746–755.
Jung, G.W., et al. (1999) The role of growth factor on regeneration of nitric oxide synthase (NOS) – containing nerves after cavernous neurotomy in the rats. Int. J. Impot. Res. 11(4), 227–235.
Ujiie, K., et al. (1994) Localization and regulation of endothelial NO synthase mRNA expression in rat kidney. Am. J. Physiol. 267(2 Pt 2), F296–F302.
Moncada, S. (1997) Nitric oxide in the vasculature: physiology and pathophysiology. Ann. NY. Acad. Sci. 811, 60–67; discussion 67–69.
Musicki, B., et al. (2004) Phosphorylated endothelial nitric oxide synthase mediates vascular endothelial growth factor-induced penile erection. Biol. Reprod. 70(2), 282–289.
Gonzalez-Cadavid, N.F., and Rajfer, J. (2005) The pleiotropic effects of inducible nitric oxide synthase (iNOS) on the physiology and pathology of penile erection. Curr. Pharm. Des. 11(31), 4041–4046.
Ferrini, M.G., et al. (2002) Antifibrotic role of inducible nitric oxide synthase. Nitric Oxide 6(3), 283–294.
Valente, E.G., et al. (2003) L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie’s fibrotic plaque and related fibroblast cultures. Nitric Oxide 9(4), 229–244.
Gholami, S.S., et al. (2003) Peyronie’s disease: a review. J. Urol. 169(4), 1234–1241.
Shi, H.P., et al. (2001) The role of iNOS in wound healing. Surgery 130(2), 225–229.
Frank, S., et al. (2002) Nitric oxide drives skin repair: novel functions of an established mediator. Kidney Int. 61(3), 882–888.
Seftel, A.D., et al. (1997) Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 50(6), 1016–1026.
Rajasekaran, M., Hellstrom, W.J., and Sikka, S.C. (2001) Nitric oxide induces oxidative stress and mediates cytotoxicity to human cavernosal cells in culture. J. Androl. 22(1), 34–39.
Burnett, A.L., et al. (1993) Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis. J. Urol. 150(1), 73–76.
Haffner, M.C., et al. (2005) Health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy in the phosphodiesterase type 5 ERA: impact of neurovascular bundle preservation. Urology 66(2), 371–376.
Gralnek, D., et al. (2000) Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy. J. Urol. 163(4), 1166–1169; discussion 1169–1170.
Kundu, S.D., et al. (2004) Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J. Urol. 172(6 Pt 1), 2227–2231.
Sunderland, S. (1977) Some anatomical and pathophysiological data relevant to facial nerve injury and repair. In: Fisch, U., ed. Facial Nerve Surgery. Birmingham, Alabama: Aesculapius Publishers.
Zippe, C.D., et al. (2001) Management of erectile dysfunction following radical prostatectomy. Curr. Urol. Rep. 2(6), 495–503.
Walsh, P.C., et al. (2000) Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 55(1), 58–61.
Walsh, P.C. (2001) Nerve grafts are rarely necessary and are unlikely to improve sexual function in men undergoing anatomic radical prostatectomy. Urology 57(6), 1020–1024.
Carrier, S., et al. (1995) Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat. J. Urol. 153(5), 1722–1727.
El-Sakka, A.I., et al. (1998) Effect of cavernous nerve freezing on protein and gene expression of nitric oxide synthase in the rat penis and pelvic ganglia. J. Urol. 160(6 Pt 1), 2245–2252.
Jung, G.W., Spencer, E.M., and Lue, T.F. (1998) Growth hormone enhances regeneration of nitric oxide synthase-containing penile nerves after cavernous nerve neurotomy in rats. J. Urol. 160(5), 1899–1904.
Andersson, K.E. (2001) Pharmacology of penile erection. Pharmacol. Rev. 53(3), 417–450.
Hedlund, H., and Andersson, K.E. (1985) Comparison of the responses to drugs acting on adrenoreceptors and muscarinic receptors in human isolated corpus cavernosum and cavernous artery. J. Auton. Pharmacol. 5(1), 81–88.
Diederichs, W., et al. (1990) Norepinephrine involvement in penile detumescence. J. Urol. 143(6), 1264–1266.
Holmquist, F., Andersson, K.E., and Hedlund, H. (1990) Actions of endothelin on isolated corpus cavernosum from rabbit and man. Acta Physiol. Scand. 139(1), 113–122.
Saenz de Tejada, I., et al. (1991) Endothelin: localization, synthesis, activity, and receptor types in human penile corpus cavernosum. Am. J. Physiol. 261(4 Pt 2), H1078–H1085.
Hedlund, H., et al. (1989) Characterization of contraction-mediating prostanoid receptors in human penile erectile tissues. J. Urol. 141(1), 182–186.
Azadzoi, K.M., et al. (1992) Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone. J. Urol. 147(1), 220–225.
Lue, T.F. (2002) Chapter 45: Physiology of Penile Erection and Pathophysiology of Erectile Dysfunction and Priapism. In: Walsh, P.C., Retik, A.B., Vaughan, E.D., and Wein, A.J., eds. Campbell’s Urology, 8th edn. Philadelphia, PA: WB Saunders Co.
Gupta, S., et al. (1995) Possible role of Na(+)-K(+)-ATPase in the regulation of human corpus cavernosum smooth muscle contractility by nitric oxide. Br. J. Pharmacol. 116(4), 2201–2206.
Draznin, M.B., Rapoport, R.M., and Murad, F. (1986) Myosin light chain phosphorylation in contraction and relaxation of intact rat thoracic aorta. Int. J. Biochem. 18(10), 917–928.
Christ, G.J., et al. (1999) Ion channels and gap junctions: their role in erectile physiology, dysfunction, and future therapy. Mol. Urol. 3(2), 61–73.
Sawada, N., et al. (2001) cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem. Biophys. Res. Commun. 280(3), 798–805.
Sauzeau, V., et al. (2000) Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J. Biol. Chem. 275(28), 21722–21729.
Gudi, T., et al. (2002) cGMP-dependent protein kinase inhibits serum-response element-dependent transcription by inhibiting rho activation and functions. J. Biol. Chem. 277(40), 37382–37393.
Chitaley, K., Webb, R.C., and Mills, T.M. (2003) The ups and downs of Rho-kinase and penile erection: upstream regulators and downstream substrates of rho-kinase and their potential role in the erectile response. Int. J. Impot. Res. 15(2), 105–109.
Wang, H., et al. (2002) RhoA-mediated Ca2+ sensitization in erectile function. J. Biol. Chem. 277(34), 30614–30621.
Rees, R.W., et al. (2002) Human and rabbit cavernosal smooth muscle cells express Rho-kinase. Int. J. Impot. Res. 14(1), 1–7.
Mills, T.M., et al. (2001) Effect of Rho-kinase inhibition on vasoconstriction in the penile circulation. J. Appl. Physiol. 91(3), 1269–1273.
Somlyo, A.P., and Somlyo, A.V. (2003) Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83(4), 1325–1358.
Somlyo, A.P., and Somlyo, A.V. (2000) Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J. Physiol. 522(Pt 2), 177–185.
Amano, M., et al. (1999) The COOH terminus of Rho-kinase negatively regulates rho-kinase activity. J. Biol. Chem. 274(45), 32418–32424.
Ming, X.F., et al. (2002) Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol. Cell Biol. 22(24), 8467–8477.
Linder, A.E., et al. (2005) Rho-kinase and RGS-containing RhoGEFs as molecular targets for the treatment of erectile dysfunction. Curr. Pharm. Des. 11(31), 4029–4040.
Hedlund, P., et al. (2000) Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice. Proc. Natl. Acad. Sci. USA 97(5), 2349–2354.
Marti, E., and Bovolenta, P. (2002) Sonic hedgehog in CNS development: one signal, multiple outputs. Trends Neurosci. 25(2), 89–96.
Machold, R., and Fishell, G. (2002) Hedgehog patterns midbrain architecture. Trends Neurosci. 25(1), 10–11.
Podlasek, C.A., et al. (1999) Prostate development requires Sonic hedgehog expressed by the urogenital sinus epithelium. Dev. Biol. 209(1), 28–39.
Niswander, L., et al. (1994) A positive feedback loop coordinates growth and patterning in the vertebrate limb. Nature 371(6498), 609–612.
Ekker, S.C., et al. (1995) Patterning activities of vertebrate hedgehog proteins in the developing eye and brain. Curr. Biol. 5(8), 944–955.
Bitgood, M.J., and McMahon, A.P. (1995) Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev. Biol. 172(1), 126–138.
Bellusci, S., et al. (1997) Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis. Development 124(1), 53–63.
Traiffort, E., et al. (2001) High expression and anterograde axonal transport of aminoterminal sonic hedgehog in the adult hamster brain. Eur. J. Neurosci. 14(5), 839–850.
Thomas, M.K., et al. (2000) Hedgehog signaling regulation of insulin production by pancreatic beta-cells. Diabetes 49(12), 2039–2047.
Pola, R., et al. The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat. Med. 7(6), 706–711.
Podlasek, C.A., et al. (2003) Sonic hedgehog cascade is required for penile postnatal morphogenesis, differentiation, and adult homeostasis. Biol. Reprod. 68(2), 423–438.
Zeng, X., et al. (2001) A freely diffusible form of Sonic hedgehog mediates long-range signalling. Nature 411(6838), 716–720.
Martin, G. (1996) Pass the butter. Science 274(5285), 203–204.
Lewis, P.M., et al. (2001) Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1. Cell 105(5), 599–612.
Gritli-Linde, A., et al. (2001) The whereabouts of a morphogen: direct evidence for short- and graded long-range activity of hedgehog signaling peptides. Dev. Biol. 236(2), 364–386.
Murone, M., Rosenthal, A., and de Sauvage, F.J. (1999) Sonic hedgehog signaling by the patched-smoothened receptor complex. Curr. Biol. 9(2), 76–84.
Lawson, N.D., Vogel, A.M., and Weinstein, B.M. (2002) Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev. Cell 3(1), 127–136.
Motoyama, J., et al. (1998) Ptch2, a second mouse Patched gene is co-expressed with Sonic hedgehog. Nat. Genet. 18(2), 104–106.
Alcedo, J., et al. (1996) The Drosophila smoothened gene encodes a seven-pass membrane protein, a putative receptor for the hedgehog signal. Cell 86(2), 221–232.
Haraguchi, R., et al. (2001) Unique functions of Sonic hedgehog signaling during external genitalia development. Development 128(21), 4241–4250.
Perriton, C.L., et al. (2002) Sonic hedgehog signaling from the urethral epithelium controls external genital development. Dev. Biol. 247(1), 26–46.
Kondo, T., et al. (1997) Of fingers, toes and penises. Nature 390(6655), 29.
Leeson, T.S., and Leeson, C.R. (1966) Penile cavernous tissue: an electron microscopic study of its development in the rat. Acta Anat. (Basel) 63(3), 404–417.
Podlasek, C.A., et al. (2007) Regulation of cavernous nerve injury-induced apoptosis by sonic hedgehog. Biol. Reprod. 76(1), 19–28.
User, H.M., et al. (2003) Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J. Urol.169(3), 1175–1179.
Klein, L.T., et al. (1997) Apoptosis in the rat penis after penile denervation. J. Urol. 158(2), 626–630.
Podlasek, C.A., et al. (2003) Altered Sonic hedgehog signaling is associated with morphological abnormalities in the penis of the BB/WOR diabetic rat. Biol. Reprod. 69(3), 816–827.
Saenz de Tejada, I., et al. (1989) Regulation of adrenergic activity in penile corpus cavernosum. J. Urol. 142(4), 1117–1121.
Saenz de Tejada, I., et al. (1989) Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N. Engl. J. Med. 320(16), 1025–1030.
Kim, Y.C., et al. (1995) Modulation of vasoactive intestinal polypeptide (VIP)-mediated relaxation by nitric oxide and prostanoids in the rabbit corpus cavernosum. J. Urol. 153(3 Pt 1), 807–810.
Hedlund, P., Alm, P., and Andersson, K.E. (1999) NO synthase in cholinergic nerves and NO-induced relaxation in the rat isolated corpus cavernosum. Br. J. Pharmacol. 127(2), 349–360.
Moreland, R.B. (1998) Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int. J. Impot. Res. 10(2), 113–120.
Tarhan, F., et al. (1997) Cavernous oxygen tension in the patients with erectile dysfunction. Int. J. Impot. Res. 9(3), 149–153.
Kim, N., et al. (1993) Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J. Clin. Invest. 91(2), 437–442.
Yao, K.S., Clayton, M., and O’Dwyer, P.J. (1995) Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. J. Natl. Cancer Inst. 87(2), 117–122.
Yamanaka, M., et al. (2002) Loss of anti-apoptotic genes in aging rat crura. J. Urol. 168(5), 2296–2300.
Daley, J.T., et al. (1996) Prostanoid production in rabbit corpus cavernosum: I. regulation by oxygen tension. J. Urol. 155(4), 1482–1487.
Nehra, A., et al. (1999) Transforming growth factor-beta1 (TGF-beta1) is sufficient to induce fibrosis of rabbit corpus cavernosum in vivo. J. Urol. 162(3 Pt 1), 910–915.
Moreland, R.B., et al. (1995) PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J. Urol. 153(3 Pt 1), 826–834.
Leungwattanakij, S., et al. (2003) Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J. Androl. 24(2), 239–245.
Granchi, S., et al. (2002) Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. Mol. Hum. Reprod. 8(12), 1053–1064.
Iacono, F., et al. (2005) Histological alterations in cavernous tissue after radical prostatectomy. J. Urol. 173(5), 1673–1676.
Ciancio, S.J., and Kim, E.D. (2000) Penile fibrotic changes after radical retropubic prostatectomy. BJU Int. 85(1), 101–106.
Savoie, M., Kim, S.S., and Soloway, M.S. (2003) A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. J. Urol. 169(4), 1462–1464.
Fraiman, M.C., Lepor, H., and McCullough, A.R. (1999) Changes in Penile morphometrics in men with erectile dysfunction after nerve-sparing radical retropubic prostatectomy. Mol. Urol.. 3(2): 109–115.
Nehra, A., et al. (1996) Mechanisms of venous leakage: a prospective clinicopathological correlation of corporeal function and structure. J. Urol. 156(4), 1320–1329.
Montorsi, F., et al. (1997) Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J. Urol. 158(4), 1408–1410.
Acknowledgements
The authors would like to thank Yi Tang from Children’s Memorial Hospital, Chicago for the electron microscopic analysis of normal penile tissue.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Modder, J., Podlasek, C.A., McVary, K.T. (2009). Pathophysiology of Erectile Dysfunction Following Radical Prostatectomy. In: Mulhall, J. (eds) Sexual Function in the Prostate Cancer Patient. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-60327-555-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-60327-555-2_3
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-554-5
Online ISBN: 978-1-60327-555-2
eBook Packages: MedicineMedicine (R0)